DSM - repurchase of shares (25-29 November 2019)
DSM repurchased 284,636 shares from 25 to 29 November 2019 at an average price of €117.00.
03 Dec 2019
Latest results & outlook
Good first nine months 2019, solid Q3
Why invest in DSM?
Our investor proposition
Growth & Value: Purpose-led, Performance-driven
Our ambitious financial targets
Share center
Our share structure, listings & performance
DSM at a glance
Key facts & figures
- q3
- why invest
- strategy
- share center
- at a glance
Purpose-led, Performance-driven
DSM is a global science-based company operating in the fields of Nutrition, Health and Sustainable Living. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above market growth.
Our story
DSM is positioned to drive continued above market organic growth and deliver further improvement in profitability, shareholder return and sustainability as we execute Strategy 2021.
Our performance
2018 has again been a record year in which we successfully completed Strategy 2016-2018, outperforming our ambitious financial and sustainability targets.
Shareholder information
We have recently celebrated the 30th anniversary of our privitisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.
“Doing well financially, doing well for the world”
Feike Sijbesma
CEO/Chairman Managing Board
- NUTRITION
- MATERIALS
Nutrition
We provide nutritional solutions for animal health and human well-being, serving the global feed, food & beverage, pharmaceutical, infant nutrition, dietary supplements and personal care industries.
2018
Sales: ↑€2,749 (2017: €2,660)
Organic Growth: ↑8%
Volume Growth: ↑4%
Price Growth: ↑4%
2018
Sales: ↑€1,989 (2017: €1,939)
Organic Growth: ↑7%
Volume Growth: ↑4%
Price Growth: ↑4%
Sales1
€5,722m
Adjusted EBITDA1
€1,117M
Adjusted EBITDA Margin1
19.5%
1) Underlying business, net of temporary vitamin effect
Materials
Advanced and high-performance materials for the electrical & electronics, automotive, packaging, consumer goods, life protection, transportation and telecom industries.
Sales
€2,913M
Adjusted EBITDA
€512M
Adjusted EBITDA Margin
17.6%
Latest financial & regulatory news
-
-
Royal DSM announces CEO succession
CEO Feike Sijbesma will hand over his responsibilities to Managing Board colleagues Geraldine Matchett and Dimitri de Vreeze as Co-CEO’s in February 2020.
02 Dec 2019
-
DSM - repurchase of shares (18-22 November 2019)
DSM repurchased 445,046 shares from 18 to 22 November 2019 at an average price of €116.60.
26 Nov 2019
Our Investor Relations team are based in Heerlen, the Netherlands. The team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. To that effect Investor Relations plans, prepares and organizes the written and oral communications with (potential) shareholders and financial analysts, deals with the stock exchange authorities and maintains the necessary databases, websites and brochures.
Dave Huizing
Vice President Investor Relations
+31 45 578 2864
Anna Morello
Investor Relations Manager
+31 45 578 2282
Marc Silvertand
Investor Relations Manager
+31 45 578 2348
Daniel Uribe
Investor Relations Analyst
+31 45 578 2864
Sandra Segers
Personal Assistant
+31 45 578 2864
Petra Volk
Support Officer
+31 45 578 2511
Read more
-
At a glance
Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.
-
Strategy & financial targets
DSM has set two ambitious targets for profit growth and cash generation to drive value creation for the period 2019-2021.
-
Latest financial results & outlook
DSM reports a good first nine months in 2019 with a solid performance in Q3.